Treatment options for HER2-positive breast cancer

What are the treatment options for recurrent metastatic HER2-positive breast cancer after trastuzumab therapy?

Personalized medicine and the role of the navigator: Prostate cancer

Molecular tests are poised to become a part of the treatment guidelines for prostate cancer.

Resection for lung cancer in the elderly: Lobectomy better than sublobar resection

Significant advances have been made in screening for lung cancer and in targeting those patients who will benefit most from it.

Nurses need education on advance health care directives

Many nurses lack the knowledge to teach patients about advance directives, but educational programs can fill the knowledge gaps.

ONA Interview: Breaking the barriers to effective palliative care

Oncology Nurse Advisor talked with Diane Meier, MD, about the components of quality palliative care.

Innovative program helps combat catheter-associated urinary tract infections

Oncology nurses reduced the rate of CAUTIs at their facility to zero by giving nurses autonomy in making care decisions for patients with urinary catheters.

Fact Sheet: Oral contraceptives and cancer risk

This fact sheet examines the relationship between oral contraception and risk of breast, ovarian, endometrial, liver, and cervical cancers.

Five Twitter feeds every oncology nurse should follow

Here are ONA's recommendations for some feeds you should be following.


Oncology Nursing

Navigation and survivorship: Rationalizing your program costs

The cost of nonbillable nursing hours needed for these programs may hinder compliance. The right technology can link treatment silos and lower this cost.


Latest News

Classifying gene mutations in neuroblastoma may point to improved treatments

Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to the drugs that target these mutations.

BRCA-related tumors respond to olaparib

Olaparib, an experimental oral cancer drug, has shown an overall tumor response rate of 26% in advanced cancers associated with BRCA1 and BRCA2 mutations, according to recent research.

Biopsies overused in diagnosing lung cancer, according to Medicare cost analysis

Biopsies are the most costly tool associated with lung cancer diagnosis, according to research.

International study shows wide differences in 5-year survival rates across the globe

There are very large differences in 5-year survival among patients with cancer between 67 countries.

Overweight and obesity status causes nearly half a million new cancer cases each year

Nearly half a million new cases of cancer each year are a result of high body mass index (BMI).

Diagnostic grading system developed for cancer-related weight loss

New grading system for cancer-linked weight loss includes independent prognostic significance of BMI and percent weight loss.

Fact Sheets

Oral Contraceptives and Cancer Risk (Fact Sheet)

Oral Contraceptives and Cancer Risk (Fact Sheet)

This fact sheet examines the relationship between oral contraception and risk of breast, ovarian, endometrial, liver, and cervical cancers.

Physical Activity and Cancer (Fact Sheet)

Physical Activity and Cancer (Fact Sheet)

This fact sheet examines the role of physical activity and exercise in cancer prevention and cancer survivorship.

Upcoming Conferences

NOV 23
Great Debates & Updates in Melanoma
Dublin, Ireland
NOV 26 - 27
3rd Munich Biomarker Conference
Munich, Germany
NOV 29
Best of Oncology 2013 East
Toronto, Ontario, Canada

Editorial Board

Ann J. Brady, MSN, RN-BC

Jiajoyce Conway, DNP, FNP-BC, AOCNP, NP-C

Frank dela Rama, RN, MS, AOCNS

Marianne Davies, DNP, ACNP, AOCNP

Donald R. Fleming, MD

Karen MacDonald, RN, BSN, CPON

Susanne Menon, MP, OCN

Leah A. Scaramuzzo, MSN, RN-BC, AOCN

Lisa A. Thompson, PharmD, BCOP

Rosemarie A. Tucci, RN, MSN, AOCN


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs